Lamotrigine
| BW-430C, BW430C | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 256.09 g/mol [1] |
| Appearance | White to pale cream-colored powder. Crystals from isopropanol [1] |
| Melting point | 177-181 [1] |
| Boiling point | 503.1±60.0 [1] |
| Solubility | 0.17 mg/mL [1] |
| Predicted LogP | 1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H7Cl2N5 |
| IUPAC name | 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine |
| SMILES | C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N |
| InChI | InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) |
| InChIKey | PYZRQGJRPPTADH-UHFFFAOYSA-N |
| CAS number | 84057-84-1 |
| UNII | U3H27498KS |
| PubChem CID | 3878 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 29 hours |
| Metabolism | Liver (mostly UGT1A4-mediated) |
| Excretion | Urine (65%), feces (2%) |
| Routes of administration | Oral (by mouth) |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - mice) LD50: 250 (mg/kg) (rat) LD50> 640 (mg/kg) (oral: 250 (mg/kg) [1] |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Light | ≤ 27.2 mg(10x - 66.7%) |
| Common | 27.2 mg |
| Strong | 25 - 50 mg(5x - 33.3%) |
| Heavy | 50 mg |
| Extreme | 50 mg + |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Lamotrigine (3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine) (also known as Lamictal Cd, Lamotrigina, Lamotriginum, Lamictal XR, Bw 430c, Lamictal ODT, 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-, 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine or Subvenite and brand names including Lamictal) is a substance of the benzylamine class.
Chemistry
Stereochemistry []
Lamotrigine is achiral.
Druglikeness
Lipinski's rule of five
Lamotrigine matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- antiepileptics (N03)
- antiepileptics (N03A)
- other antiepileptics (N03AX)
- (N03AX09)
- lamotrigine (N03AX09)
MeSH Classification
- anticonvulsants (M0001382)
- calcium channel blockers (M0003165)
- antipsychotic agents (M0021770)
- sodium channel blockers (M0379271)
Mechanism of action []
The exact mechanism of action of lamotrigine is not fully elucidated, as it may exert cellular activities that contribute to its efficacy in a range of conditions. Although chemically unrelated, lamotrigine actions resemble those of phenytoin and carbamazepine, inhibiting voltage-sensitive sodium channels, stabilizing neuronal membranes, thereby modulating the release of presynaptic excitatory neurotransmitters. Lamotrigine likely acts by inhibiting sodium currents by selective binding to the inactive sodium channel, suppressing the release of the excitatory amino acid, glutamate. The mechanism of action of lamotrigine in reducing anticonvulsant activity is likely the same in managing bipolar disorder. Studies on lamotrigine have identified its binding to sodium channels in a fashion similar to local anesthetics, which could explain the demonstrated clinical benefit of lamotrigine in some neuropathic pain states. Lamotrigine displays binding properties to several different receptors. In laboratory binding assays, it demonstrates weak inhibitory effect on the serotonin 5-HT3 receptor. Lamotrigine also weakly binds to Adenosine A1/A2 receptors, α1/α2/β adrenergic receptors, dopamine D1/D2 receptors, GABA A/B receptors, histamine H1 receptors, κ-opioid receptor (KOR), mACh receptors and serotonin 5-HT2 receptors with an IC50>100 µM. Weak inhibitory effects were observed at sigma opioid receptors. An in vivo study revealed evidence that lamotrigine inhibits Cav2.3 (R-type) calcium currents, which may also contribute to its anticonvulsant effects. [1]
Interactions []
Medical side effects []
344 side effects listed on drug labels in SIDER 4.1 (lamotrigine).
- Diplopia
- Injury
- Somnolence
- Drowsiness
- Vision blurred
- Ataxia
- Dizziness
- Syncope
- Nausea
- Pharyngitis
- Vomiting
- Back pain
- Diarrhoea
- Asthenia
- Fatigue
- Bronchitis
- Influenza
- Rhinitis
- Cough
- Abdominal pain
- Gastrointestinal pain
- Body temperature increased
- Dry mouth
- Action tremor
- Coordination abnormal
- Menstrual disorder
- Amblyopia
- Infection
- Confusional state
- Feeling abnormal
- Malaise
- Dysmenorrhoea
- Dyspepsia
- Dermatitis
- Rash
- Pain
- Paraesthesia
- Insomnia
- Tremor
- Anxiety
- Constipation
- Depression
- Anxiety depression
- Vaginal inflammation
- Vaginal infection
- Mood swings
- Affect lability
- Gait disturbance
- Headache
- Asthma
- Irritability
- Mediastinal disorder
- Pneumonia
- Pruritus
- Speech disorder
- Urinary tract infection
- Balance disorder
- Unsteadiness
- Laryngeal pain
- Chest pain
- Amenorrhoea
- Amnesia
- Decreased appetite
- Arthralgia
- Musculoskeletal discomfort
- Myalgia
- Balanitis
- Bronchospasm
- Neck pain
- Connective tissue disorder
- Ear disorder
- Eczema
- Haemorrhage
- Haemoglobin
- Nervousness
- Tension
- Nystagmus
- Penis disorder
- Convulsion
- Sinusitis
- Skin ulcer
- Angiopathy
- Vertigo
- Weight decreased
- Photosensitivity reaction
- Lymphadenopathy
- Face oedema
- Infestation
- Malnutrition
- Blepharitis
- Dermatitis contact
- Dyspnoea
- Keratitis
- Nail disorder
- Peptic ulcer
- Aphthous stomatitis
- Tooth disorder
- Agitation
- Hyperkinesia
- Eye pain
- Sore eye
- Hyporeflexia
- Hyperreflexia
- Rectal haemorrhage
- Laboratory test abnormal
- Alopecia
- Aphasia
- Arthritis
- Conjunctivitis
- Libido decreased
- Disturbance in sexual arousal
- Libido increased
- Dysphagia
- Depersonalisation
- Dysarthria
- Osteoarthritis
- Arthropathy
- Dysgeusia
- Dyskinesia
- Movement disorder
- Ear pain
- Ecchymosis
- Epistaxis
- Eructation
- Flushing
- Gastritis
- Gingivitis
- Breath odour
- Hallucination
- Haematuria
- Hirsutism
- Hostility
- Hypersensitivity
- Hypertension
- Orthostatic hypotension
- Muscle spasms
- Leukopenia
- Breast pain
- Menorrhagia
- Hypertonia
- Myoclonus
- Palpitations
- Personality disorder
- Polyuria
- Urine output increased
- Psychotic disorder
- Salivary hypersecretion
- Hyperhidrosis
- Shock
- Loss of consciousness
- Tachycardia
- Tinnitus
- Pollakiuria
- Micturition urgency
- Urinary incontinence
- Urticaria
- Vasodilation procedure
- Weight increased
- Yawning
- Chills
- Stupor
- Depressed level of consciousness
- CNS depression NOS
- Apathy
- Flat affect
- Photophobia
- Oedema peripheral
- Panic attack
- Stomatitis
- Mouth ulceration
- Migraine
- Liver function test abnormal
- Paranoia
- Aspartate aminotransferase increased
- Skin discolouration
- Dry skin
- Accommodation disorder
- Discomfort
- Ill-defined disorder
- Muscle twitching
- Increased appetite
- Abnormal dreams
- Euphoric mood
- Urine abnormality
- Urine analysis abnormal
- Erectile dysfunction
- Dry eye
- Akathisia
- Rash maculo-papular
- Suicidal ideation
- Menopausal symptoms
- Hot flush
- Acne
- Sleep disorder
- Muscular weakness
- Ejaculation disorder
- Hypoaesthesia
- Abscess
- Agranulocytosis
- Anaemia
- Aplastic anaemia
- Haemolytic anaemia
- Anaemia macrocytic
- Angina pectoris
- Angioedema
- Apnoea
- Atrial fibrillation
- Bipolar disorder
- Bipolar I disorder
- Bursitis
- Vulvovaginal candidiasis
- Vulvovaginal mycotic infection
- Cerebellar syndrome
- Nervous system disorder
- Cystitis
- Bladder pain
- Cystitis noninfective
- Deafness
- Delirium
- Delusion
- Dermatitis exfoliative
- Fungal skin infection
- Disseminated intravascular coagulation
- Dysuria
- Oedema
- Eosinophilia
- Epididymitis
- Grand mal convulsion
- Erythema multiforme
- Stevens-Johnson syndrome
- Oesophagitis
- Extrapyramidal disorder
- Gastrointestinal haemorrhage
- Gingival bleeding
- Gingival hyperplasia
- Glossitis
- Goitre
- Haematemesis
- Hemiplegia
- Hepatitis
- Herpes zoster
- Hiccups
- Hyperpathia
- Hyperaesthesia
- Hyperbilirubinaemia
- Hyperglycaemia
- Hyperventilation
- Hypothyroidism
- Renal failure acute
- Lacrimal disorder
- Lacrimal structural disorder
- Leukocytosis
- Lymphocytosis
- Melaena
- Meningitis aseptic
- Multi-organ failure
- Hypotonia
- Muscle relaxant therapy
- Muscle atrophy
- Myocardial infarction
- Acute coronary syndrome
- Neuralgia
- Neuritis
- Neuropathy peripheral
- Neurosis
- Neutropenia
- Nocturia
- Pancreatitis
- Pancytopenia
- Parkinson's disease
- Parkinsonism
- Petechiae
- Renal failure
- Rhabdomyolysis
- Scotoma
- Seborrhoeic dermatitis
- Gastric ulcer
- Cerebrovascular accident
- Completed suicide
- Suicide attempt
- Thirst
- Thrombocytopenia
- Thrombophlebitis
- Thrombosis
- Erythema
- Uveitis
- Vasculitis
- Urinary retention
- Choreoathetosis
- Rash pustular
- Vesiculobullous rash
- Hypokinesia
- Breast abscess
- Alcohol intolerance
- Enterocolitis haemorrhagic
- Tongue disorder
- Tongue oedema
- Galactorrhoea
- Dermatitis bullous
- Alanine aminotransferase increased
- Tendinous contracture
- Iron deficiency anaemia
- Leukoderma
- Dysphoria
- Anorgasmia
- Hypomania
- Aplasia pure red cell
- Abdominal distension
- Systemic lupus erythematosus
- Oscillopsia
- Paralysis
- Renal pain
- Breast neoplasm
- Parosmia
- Ageusia
- Apraxia
- Mental disorder
- Breast feeding
- Coma
- Cushing's syndrome
- Toxic epidermal necrolysis
- Eye disorder
- Facial pain
- Flatulence
- Gastrointestinal disorder
- Cardiac arrest
- Cardiac failure
- Blood disorder
- Nephropathy
- Nasal congestion
- Status epilepticus
- Hepatic failure
- Drug withdrawal syndrome
- Altered state of consciousness
- Clonic convulsion
- Drug withdrawal convulsions
- Lip swelling
- Mania
- Organ failure
- Drug reaction with eosinophilia and systemic symptoms
- Drug interaction
- Sudden unexplained death in epilepsy
- Oral pain
- Suicidal behaviour
Indications
- Affective disorder
- Bipolar disorder
- Bipolar I disorder
- Convulsion
- Convulsions generalised
- Epilepsy
- Grand mal convulsion
- Hepatic function abnormal
- Hypomania
- Lennox-Gastaut syndrome
- Mania
- Partial seizures
- Renal failure
- Renal impairment
Subjective effects []
| emily / Lamotrigine [] | |
|---|---|
Routes:
| |
| Pilz / Lamotrigine [] | |
|---|---|
Routes:
| |
Legal status []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3878, Lamotrigine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3878
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lamotrigine. UNII: U3H27498KS. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/U3H27498KS
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Lamictal XR- lamotrigine tablet, film coated, extended release Lamictal XR- lamotrigine kit. DailyMed. 13 April 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e2c9a35-6a39-41d7-ad84-3c0bb8894b09
Lamictal. European Medicines Agency. 17 September 2018. https://www.ema.europa.eu/en/medicines/human/referrals/lamictal
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 11:14:51 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 11:14:47 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 11:14:47 |
| gsrs | ok | 2026-11-20 11:14:47 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014695) | 2026-11-20 11:14:47 |
| kegg | ok | 2026-11-20 11:14:48 |
| pubchem | ok | 2026-11-20 11:14:47 |
| missing (no r/tripreports posts mention it) | 2026-11-20 11:14:47 | |
| sider | ok | 2026-11-20 11:14:48 |
| structure | ok | 2026-11-20 11:14:47 |
| wikipedia | ok | 2026-11-20 11:14:47 |